Founded in 1991, Albany Molecular Research, Inc. (Nasdaq: AMRI) is a chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications.

For over a decade, Albany Molecular Research, Inc. has helped pharmaceutical and biotechnology companies accelerate the movement of products through the discovery and development pipeline. From lead discovery and optimization, through process development, and on to cGMP manufacturing -- all with a fanatical devotion to quality, speed, and customer satisfaction.